Effect of taxanes following anthracyclines on pathologic complete response (pCR) in patients with triple-negative breast cancer (TNBC) receiving primary systemic therapy (PST).

e13129 Background: TNBC is an aggressive molecular subtype associated with increased risk of distant metastases and poor prognosis. In this study we report response to PST and clinical outcome of a...